UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 新型コロナウイルス感染症：ワクチンcovid 19 vaccines [show details]
… Providing booster doses – The FDA and CDC indicate that a booster dose can be a different vaccine than the one used for the primary series (ie, a heterologous boost). Options for booster dosing depend …
2. 成人のB型肝炎ワクチン接種hepatitis b virus immunization in adults [show details]
… at age 15 years received a booster dose of the vaccine; a titer of ≥10 milli-international units/mL was seen in approximately 93 percent six weeks after receiving the booster dose. However, there was no …
3. Practice Changing UpDatespractice changing updates [show details]
…recommend a booster dose (Grade 1B). For individuals <12 years old, a monovalent vaccine is used for the booster dose. For individuals ≥12 years old, a bivalent mRNA vaccine is used for the booster dose. For …
4. 特異的抗体欠損specific antibody deficiency [show details]
…time lapse since prior vaccines or a failure to receive the full series of vaccines or to receive booster doses. The diagnosis of SAD is made in a patient older than two years of age with recurrent or severe…
5. HIV感染症の治療に用いる抗レトロウイルス薬の概要overview of antiretroviral agents used to treat hiv [show details]
… with a pharmacokinetic booster, as in rilpivirine-emtricitabine-tenofovir alafenamide and bictegravir-emtricitabine-tenofovir alafenamide, the dose is 25 mg. Pharmacologic boosting agents (eg, cobicistat …